SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* ROCHE HOLDING LTD (Last) (First) (Middle) GRENZACHERSTRASSE 124, 4070 (Street) BASEL V8 CH-4070 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/24/2021	3. Issuer Name and Ticker or Trading Symbol Jasper Therapeutics, Inc. [ JSPR ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Voting Common Stock	4,624,606	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* ROCHE HOLDING LTD (Last) (First) (Middle) GRENZACHERSTRASSE 124, 4070 (Street) BASEL V8 CH-4070 (City) (State) (Zip)

1. Name and Address of Reporting Person* ROCHE FINANCE LTD (Last) (First) (Middle) GRENZACHERSTRASSE 122, 4070 (Street) BASEL V8 (City) (State) (Zip)

Explanation of Responses:

1. Roche Finance Ltd ("Roche Finance") is the direct beneficial owner of these securities of the Issuer. Roche Finance is a wholly-owned subsidiary of Roche Holding Ltd, a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding Ltd is the indirect beneficial owner of these securities of the Issuer.

	ROCHE FINANCE LTD By: /s/ Beat Kraehenmann Name: Beat Kraehenmann Title: Authorized Signatory	10/04/2021
	By: /s/ Carole Nuechterlein Name: Carole Neuchterlein Title: Authorized Signatory	10/04/2021
	ROCHE HOLDING LTD By: /s/ Beat Kraehenmann Name: Beat Kraehenmann Title: Authorized Signatory	10/04/2021
	By: /s/ Claudia Boeckstiegel Name: Claudia Boeckstiegel Title: Authorized Signatory	10/04/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.